Insomnia in the Elderly: Cause, Approach, and Treatment

American Journal of Medicine

Volumn 119, Issue 6, 2006, Pages 463-469

  Kamel, Nabil S ^a,b   Gammack, Julie K ^a,b  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Elderly; Insomnia; Sleep

Indexed keywords

ADRENERGIC RECEPTOR STIMULATING AGENT; ALCOHOL; AMPHETAMINE DERIVATIVE; ANTIDEPRESSANT AGENT; ANTIHISTAMINIC AGENT; ANTIHYPERTENSIVE AGENT; ANTIPARKINSON AGENT; BENZODIAZEPINE DERIVATIVE; BRONCHODILATING AGENT; CAFFEINE; CARDIOVASCULAR AGENT; CENTRAL STIMULANT AGENT; DECONGESTIVE AGENT; EPHEDRINE; ESZOPICLONE; HERBACEOUS AGENT; HISTAMINE H2 RECEPTOR ANTAGONIST; INDIPLON; LAXATIVE; MELATONIN; PHENYLPROPANOLAMINE; PHENYTOIN; PSYCHOTROPIC AGENT; RAMELTEON; TEMAZEPAM; TRAZODONE; UNCLASSIFIED DRUG; UNINDEXED DRUG; ZALEPLON; ZOLPIDEM; ZOPICLONE;

AGED; AGING; AGITATION; ANTICHOLINERGIC EFFECT; BEHAVIOR; BEHAVIOR DISORDER; BEHAVIOR THERAPY; CARDIOTOXICITY; CARDIOVASCULAR RISK; CIRCADIAN RHYTHM; CIRCADIAN RHYTHM SLEEP DISORDER; CLINICAL TRIAL; COGNITIVE DEFECT; COGNITIVE THERAPY; DAYTIME SOMNOLENCE; DIZZINESS; DROWSINESS; DRUG DEPENDENCE; DRUG EFFICACY; DRUG HALF LIFE; DRUG INDUCED HEADACHE; DRUG SAFETY; DRUG TOLERANCE; ELDERLY CARE; ENVIRONMENTAL FACTOR; FALLING; FATIGUE; GASTROINTESTINAL SYMPTOM; HANGOVER; HEALTH CARE UTILIZATION; HEALTH PRACTITIONER; HIP FRACTURE; HUMAN; HYPOTENSION; INSOMNIA; INTERMETHOD COMPARISON; LIGHT EXPOSURE; LIMB MOVEMENT; LONG TERM CARE; LONG TERM MEMORY; LOW DRUG DOSE; MEDICAL ASSESSMENT; MEMORY DISORDER; MOTOR DYSFUNCTION; NAUSEA; NIGHT SLEEP; PARASOMNIA; PHOTOTHERAPY; PHYSICAL DISEASE; PHYSIOLOGY; PRIORITY JOURNAL; PSYCHOMOTOR DISORDER; QUALITY OF LIFE; REBOUND; RELAXATION TRAINING; REM SLEEP; RESTLESS LEGS SYNDROME; REVIEW; SEDATION; SHORT COURSE THERAPY; SHORT TERM MEMORY; SIDE EFFECT; SLEEP; SLEEP APNEA SYNDROME; SLEEP DEPRIVATION; SLEEP DISORDER; SLEEP PARAMETERS; SLEEP STAGE; SLEEP WAKING CYCLE; SLOW WAVE SLEEP; TACHYCARDIA; TRAFFIC ACCIDENT; TREATMENT INDICATION; UNSPECIFIED SIDE EFFECT; WAKEFULNESS; WITHDRAWAL SYNDROME; XEROSTOMIA;

ACETAMIDES; AGED; AGING; ANTIDEPRESSIVE AGENTS; BEHAVIOR THERAPY; BENZODIAZEPINES; DRUGS, NON-PRESCRIPTION; HUMANS; HYPNOTICS AND SEDATIVES; PIPERAZINES; PYRIDINES; PYRIMIDINES; RECEPTOR, MELATONIN, MT1; RECEPTOR, MELATONIN, MT2; SLEEP; SLEEP INITIATION AND MAINTENANCE DISORDERS; SLEEP, REM; THIOPHENES; TRAZODONE;

EID: 33646923436     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjmed.2005.10.051     Document Type: Review

References (47)

1. Woodward M. Insomnia in the elderly. Aust Fam Physician 28 (1999) 653-658
2. Foley D.J., Monjan A., Simonsick E.M., et al. Incidence and remission of insomnia among elderly adults. an epidemiologic study of 6,800 persons over three years. Sleep 22 S2 (1999) S366-S372
3. Schubert C.R., Cruickshanks K.J., Dalton D.S., et al. Prevalence of sleep problems and quality of life in an older population. Sleep 25 (2002) 889-893
4. Baber S.I., Enright P.L., Boyle P., et al. Sleep disturbances and their correlates in elderly Japanese American men residing in Hawaii. J Gerontology A Biol Sci Med Sci 55A (2000) M406-M411
5. Foley D.J., Monjan A.A., Brown S.L., et al. Sleep complaints among elderly persons. an epidemiologic study of three communities. Sleep 18 (1995) 425-432
6. Sukying C., Bhokakul V., and Udomsubpayakul U. An epidemiological study on insomnia in an elderly Thai population. J Med Assoc Thai 86 (2003) 316-324
7. Chlu H.F.K., Leung T., Lam L.C.W., et al. Sleep problems in Chinese elderly in Hong Kong. Sleep 22 (1999) 717-726
8. Maggi S., Langlois J.A., Minicuci N., et al. Sleep complaints in community-dwelling older persons. prevalence, associated factors and reported causes. J Am Geriatr Soc 46 (1998) 161-168
9. Neubauer D.N. Sleep problems in the elderly. Am Fam Physician 59 (1999) 2551-2558
10. Rajput V., and Bromley S.M. Chronic insomnia. a practical review. Am Fam Physician 60 (1999) 1431-1438
11. Montgomery P. Treatments for sleep problems in elderly people. Br Med J 325 (2002) 1049
12. McCall W.V. Sleep in the elderly. burden, diagnosis and treatment. Prim Care Companion J Clin Psychiatry 6 (2004) 9-20
13. National Institutes of Health state-of-the-science conference statement on manifestations and management of chronic insomnia in adults. June 13-15, 2005; Final Statement August 18,1005. Available at: http://consensus.nih.gov/2005/2005insomniaS0S026html.htm. Accessed August 26, 2005.
14. Feinsilver S.H. Sleep in the elderly. What is normal?. Clin Geriatr Med 19 (2003) 177-188
15. Dement W., Richardson G., and Prinz P. Changes of sleep and wakefulness with age. In: Finch C., and Schneider E.L. (Eds). Handbook of the Biology of Aging. 2nd edition (1985), Van Nostrand Reinhold, New York 692-717
16. John M.W. A new method for measuring daytime sleepiness. the Epworth sleepiness scale. Sleep 14 (1991) 540-545
17. Woodward M. Hypnosedatives in the elderly. A guide to appropriate use. CNS Drugs 11 (1999) 263-279
18. Ancoli-Israel S. Sleep problems in older adults. putting myths to bed. Geriatrics 52 (1997) 20-30
19. Vgontzas A.N., and Kales A. Sleep and its disorders. Annu Rev Med 50 (1999) 387-400
20. Grunstein R. Insomnia. Diagnosis and management. Aust Fam Physician 31 (2002) 1-6
21. Brassington G.S., King A.C., and Bliwise D.L. Sleep problems as a risk factor for falls in a sample of community-dwelling adults aged 64-99 years. J Am Geriatr Soc 48 (2000) 1234-1240
22. Cricco M., Simonsick E.M., and Foley D.J. The impact of insomnia on cognitive functioning in older adults. J Am Geriatr Soc 49 (2001) 1185-1189
23. Manabe K., Matsui T., Yamaya M., et al. Sleep patterns and mortality among elderly patients in a geriatric hospital. Gerontology 46 (2000) 318-322
24. Spiegel K., Tasali E., Penev P., et al. Brief communication. sleep curtailment in healthy young men is associated with decreased leptin levels, elevated ghrelin levels, and increased hunger and appetite. Ann Intern Med 141 (2004) 846-850
25. Ogawa Y., Kanbayashi T., Saito Y., et al. Total sleep deprivation elevates blood pressure through arterial baroreflex resetting. a study with microneurographic technique. Sleep 26 (2003) 986-999
26. Meier-Ewert H.K., Ridker P.M., Rifai N., et al. Effect of sleep loss on C-reactive protein, an inflammatory marker of cardiovascular risk. J Am Coll Cardiol 43 (2004) 678-683
27. Gottlieb D.J., Punjabi N.M., Newman A.B., et al. Association of sleep time with diabetes mellitus and impaired glucose tolerance. Arch Intern Med 165 (2005) 863-867
28. Kupfer D.J., and Reynolds C.F. Management of insomnia. N Engl J Med 336 (1997) 341-346
29. Obermeyer W.H., and Benca R.M. Effects of drugs on sleep. Neurol Clin 14 (1996) 827-840
30. Roth T., Hajak G., and Üstün T.B. Consensus for the pharmacological management of insomnia in the new millennium. Int J Clin Pract 55 (2001) 42-52
31. Shochat T., Loredo J., and Ancoli-Israel S. Sleep disorders in the elderly. Curr Treat Options Neurol 3 (2001) 19-36
32. Morin C.M., Colecchi C., Stone J., et al. Behavioral and pharmacological therapies for late-life insomnia. A randomized controlled trial. JAMA 281 (1999) 991-999
33. Smith M.T., Perlis M.L., Park A., et al. Comparative meta-analysis of pharmacotherapy and behavior therapy for persistent insomnia. Am J Psychiatry 159 (2002) 5-11
34. Kobayashi R., Kohsaka M., Fukuda N., et al. Effects of morning bright light on sleep in healthy elderly women. Psychiatry Clin Neurosci 53 (1999) 237-238
35. Fetveit A., Skjerve A., and Bjorvatn B. Bright light treatment improves sleep in institutionalized elderly-an open trial. Int J Geriatr Psychol 18 (2003) 520-526
36. Holm K.J., and Goa K.L. Zolpidem. An update of its pharmacology, therapeutic efficacy and tolerability in the treatment of insomnia. Drugs 59 (2000) 865-889
37. Ancoli-Israel S., Richardson G.S., and Mangano R.M. Long-term use of sedative hypnotics in older patients with insomnia. Sleep Med 6 (2005) 107-113
38. Ancoli-Israel S., Walsh J.K., Mangano R.M., et al. Zaleplon, a novel nonbenzodiazepine hypnotic, effectively treats insomnia in elderly patients without causing rebound effects. Prim Care Companion J Clin Psychiatry 1 (1999) 114-120
39. Scharf M., Seiden D., Erman M., et al. Eszopiclone rapidly induced sleep and provided sleep maintenance in elderly patients with chronic insomnia (2003), 11th Congress of the International Psychogeriatric Association, Chicago, Ill August 17-22
40. Melton ST, Wood JM, Kirkwood CK. Eszopiclone for insomnia. Ann Pharmacother. August 30, 2005; E-publication.
41. Walsh J.K., Lankford D.D., Krystal A., et al. Efficacy and tolerability of four doses of indiplon (NBI-34060) modified-release in elderly patients with sleep maintenance insomnia. Sleep 26 (2003) A78
42. Scharf M.B., Rosenberg R., Cohn M., et al. Safety and efficacy of immediate release indiplon (NBI-34060) in elderly patients with insomnia. Sleep 26 (2003) A85
43. Walsh J.K., and Schweitzer P.K. Ten-year trends in the pharmacological treatment of insomnia. Sleep 22 (1999) 371-375
44. Haria M., Fitton A., and McTavish D. Trazodone. A review of its pharmacology, therapeutic use in depression and therapeutic potential in other disorders. Drugs & Aging 4 (1994) 331-355
45. Roth T., Seiden D., Zee P., et al. Phase III outpatient trial of Ramelteon for the treatment of chronic insomnia in elderly patients. J Am Geriatr Soc 53 (2005) S25
46. Peck J.S., LeGoff D.B., Ahmed I., et al. Cognitive effects of exogenous melatonin administration in elderly persons. a pilot study. Am J Geriatr Psychiatry 12 (2004) 432-436
47. Stevinson C., and Ernst E. Valerian for insomnia. a systematic review of randomized clinical trials. Sleep Med 1 (2000) 91-99